Loading…

Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing

Background COVID-19 infection is a major threat to patients and health care providers around the world. One solution is the vaccination against SARS-CoV-2. Methods We performed a comprehensive query of the latest publications on the prevention of viral infections including the recent vaccination pro...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medical research 2021-08, Vol.26 (1), p.1-3, Article 87
Main Authors: Fischer, Johannes C, Schmidt, Albrecht G, Bölke, Edwin, Keitel, Verena, Feldt, Torsten, Jensen, Björn, Freise, Noemi F, Häussinger, Dieter, Schneider, E. Marion, Hermsen, Derik, Kindgen-Milles, Detlef, Knoefel, Wolfram Trudo, Haussmann, Jan, Tamaskovics, Balint, Plettenberg, Christian, Scheckenbach, Kathrin, Corradini, Stefanie, Rox, Jutta, Balz, Vera, Maas, Kitti, Schmidt, Livia, Grebe, Olaf, Erhardt, Anja, Gerber, Peter Arne, Peiper, Matthias, Buhren, Bettina Alexandra, Lichtenberg, Artur, Rezazadeh, Amir, Budach, Wilfried, Matuschek, Christiane
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background COVID-19 infection is a major threat to patients and health care providers around the world. One solution is the vaccination against SARS-CoV-2. Methods We performed a comprehensive query of the latest publications on the prevention of viral infections including the recent vaccination program and its side effects. Results The situation is evolving rapidly and there is no reasonable alternative to population-scale vaccination programs as currently enrolled. Conclusion Therefore, regulatory authorities should consider supplementing their conventional mandate of post-approval pharmacovigilance, which is based on the collection, assessment, and regulatory response to emerging safety findings.
ISSN:2047-783X
0949-2321
2047-783X
DOI:10.1186/s40001-021-00558-y